Mm.

So, you know, that, that really talks about the kind of continuity of care, which I think we're really, really committed to.

Um, in terms of research, I'm, I'm, I have to own being quite a dismal researcher, uh, and my focus very much is on using research to, um, really answer questions for the patients that I see in clinic.

And I guess my main role in this space is, is partly phenotyping rare diseases, but I'm very dependent on my colleagues like Jo, who really understands epilepsy at a level I never begin to even understand, but also in interpreting genomic variants and what they may mean clinically-

Mm

... where we see fetuses with particular abnormalities or at risk of genetic disorders.

And, you know, one of the big bonuses of having a genetic answer is having a clear idea of what it might mean for either future children of the same parents or for the next generation.

So, you know, this really is an important area for us, um, and to empower people to make the decisions that are right for themselves-